nutrition & liver disease
TRANSCRIPT
-
7/30/2019 Nutrition & Liver Disease
1/27
Nutrition & Liver Disease
Dr Nugroho Abikusno
Medical NutritionTrisakti University Jakarta
-
7/30/2019 Nutrition & Liver Disease
2/27
The major forms of liver disease are:
Acute viral hepatitis
Fulminant hepatitis
Chronic hepatitis Alcoholic hepatitis
Cirrhosis
Cholestatic liver diseases Primary biliary cirrhosis
Sclerosing cholangitis
-
7/30/2019 Nutrition & Liver Disease
3/27
Inherited Disorders
Hemochromatosis
Inherited disease of iron overload
Wilsons diseaseAutosomal recessive disorder
associated with impaired biliary copper
excretion 1-antitrypsin deficiency
Causes cholestasis or cirrhosis and can cause
liver and lung cancer
-
7/30/2019 Nutrition & Liver Disease
4/27
Other Liver Diseases
Several other causes of liver disease, including
Liver tumors
Systemic diseases (rheumatoidarthritis, systemic sclerosis)
Nonalcoholic steatohepatitis
Acute ischemic and chroniccongestive hepatopathy
Parasitic, bacterial, fungal, and
granulomatous liver diseases
-
7/30/2019 Nutrition & Liver Disease
5/27
Common Laboratory Tests Used to Test
for Liver Function
Hepatic excretion
- Total serum bilirubin, urine bilirubin
Cholestasis tests- Serum alkaline phosphatase
Hepatic enzymes
- ALT, AST
-
7/30/2019 Nutrition & Liver Disease
6/27
cont
Serum proteins
- PT, PTT, serum albumin
Markers of specific liver diseases- Serum ferritin, ceruloplasmin
Specific tests for viral hepatitis
- IgM anti-HAV, anti-HBS, HCV-RNA
-
7/30/2019 Nutrition & Liver Disease
7/27
End-Stage Alcoholic Liver Disease
Possible Characteristics
Malnutrition
Portal hypertension with varices
Ascites Hyponatremia
Hepatic encephalopathy
Glucose alterations
-
7/30/2019 Nutrition & Liver Disease
8/27
cont
Fat malabsorption
Osteopenia
Thrombocytopenia with anemia
-
7/30/2019 Nutrition & Liver Disease
9/27
Clinical Manifestations of Cirrhosis
Icteric sclerae
Palmar erythema
Ascites Testicular atrophy
Edema
Muscle wasting Jaundice
Bruising
-
7/30/2019 Nutrition & Liver Disease
10/27
Clinical Manifestations of Cirrhosis
Encephalopathy
Esophageal varices
Portal hypertension Cirrhosis
Hepatorenal syndrome
Tea-colored urine Clay-colored stool
-
7/30/2019 Nutrition & Liver Disease
11/27
Malnutrition in Liver DiseaseCause
Anorexia (inadequate oral intake)
Early satiety or dysgeusia
Nausea and vomiting Maldigestion and malabsorption
Altered metabolism
Restricted diets
-
7/30/2019 Nutrition & Liver Disease
12/27
Amino Acids Commonly Altered
in Liver Disease Aromatic amino acidsserum levels increased
Tyrosine
Phenylalanine*
Free tryptophan*
Branched-chain amino acidsserum levels decreasedValine*
Leucine*
Isoleucine*
Other amino acidsserum levels increased
Methionine*Glutamine
Asparagine
Histidine*
-
7/30/2019 Nutrition & Liver Disease
13/27
Nutrition Assessment Tests Affected in
Patients with End-Stage Renal Disease
Body weight
Anthropometric
measurements
Creatinine-height index
Nitrogen balance
studies
3-methylhistidine
excretion
Visceral protein levels
Immune function tests
-
7/30/2019 Nutrition & Liver Disease
14/27
Medical management
Diuretic therapy
Medication for encephalopathy (eg. Lactulose
& neomycin)
Management of portal hypertensive bleeding
(eg. Pharmacologic therapy, shunts, banding)
Monitoring of blood glucose
-
7/30/2019 Nutrition & Liver Disease
15/27
Medical nutrition therapy for cirrhosis
Recommend smaller meals because of early
satiety and anorexia; smaller meals also may
help to promote a positive nitrogen balance
and prevention of hypoglycemia
Recommend oral nutritional supplements
Consider nutritional support, if patient is
unable to consume 0.8 g protein g/kg/day and
30 kcal/kg/day
-
7/30/2019 Nutrition & Liver Disease
16/27
cont
Patient may necessitate 120%-140% of REE inend-stage liver disease without ascites; and up to150%-175% of REE if ascites, malabsorption, orinfection is present
Make sure to obtain dry weights for reassessmentpurposes
Liver failure reduces glucose production anddecreases peripheral utilization; coupled with a
change in hormones, such as insulin, glucagon,cortisol, and epinephrine, the body developspreference for lipids and amino acids
-
7/30/2019 Nutrition & Liver Disease
17/27
cont
Twenty-five percent to 40% of total caloriesshould come from lipid
Patient should receive 1.2-1.3 g protein/kg/day to
promote positive nitrogen balance; 1.5 gprotein/kg/day if patient shows signs of severeascites or gastrointestinal bleeding
Vitamin and mineral supplementation
recommended for end-stage liver diseaseincludes all of the B vitamins and all of the fat-soluble vitamins
-
7/30/2019 Nutrition & Liver Disease
18/27
cont
Wernickes encephalopathyrecommend
thiamine, vitamin B6, vitamin B12, folate, and
niacin
Iron supplementation recommended in cases ofgastrointestinal bleeding
Zinc, magnesium, and copper are malabsorbed in
chronic liver disease with steatorrhea Between 10% and 37% of patients with cirrhosis
will develop overt diabetes mellitus
-
7/30/2019 Nutrition & Liver Disease
19/27
Medical nutrition therapy for portal
hypertension
Acute stageinitiation of TPN probably
necessary
Repeated endoscopic therapy is likely to cause
esophageal stricture or dysphagia
Shunt placement increases the risk of
encephalopathy and reduces nutrient
metabolism
-
7/30/2019 Nutrition & Liver Disease
20/27
Medical nutrition therapy for ascites
Recommend fluid restriction
Watch for loop diuretic side effects, includinghyponatremia, hypokalemia,
hypomagnesemia, hypocalcemia, andhypochloremic acidosis
Monitor weight, abdominal girth, urinary
sodium concentration, BUN, creatinine,albumin, uric acid, and electrolyte levels, ifpatient is prescribed diuretics
-
7/30/2019 Nutrition & Liver Disease
21/27
cont
Recommend 2 g/day for sodium restriction
Ensure that patient receives adequate protein
M di l t iti th f h ti
-
7/30/2019 Nutrition & Liver Disease
22/27
Medical nutrition therapy for hepatic
encephalopathy (including fulminant
hepatitis) Ammonia is an important causative factor,because the liver can not detoxify ammonia to
urea
Some people believe that dietary protein
causes an increase in ammonia production,
but this is unproven; protein restriction is not
recommended, with some studies showingthat this practice is possibly quite harmful
-
7/30/2019 Nutrition & Liver Disease
23/27
cont
A branched-chain amino acid formula isrecommended for patients who cannot toleratestandard protein sources and are nonresponsive
to medication Some studies have shown that vegetable protein
and casein are the preferred sources of proteinfor patients with hepatic encephalopathy,
because they contain less aromatic amino acidsand more branched-chain amino acids than othersources of protein
-
7/30/2019 Nutrition & Liver Disease
24/27
cont
Monitor glucose regularly
Vitamin K supplementation is recommended
-
7/30/2019 Nutrition & Liver Disease
25/27
Medical nutrition therapy for fat
malabsorption in liver disease
Replace long-chain triglycerides with medium-
chain triglycerides, because they are more
readily digestible
Recommend a 40-g fat diet; if diarrhea does
not resolve quickly as a result of this diet,
discontinue the diet because of the risk of
furthering malnutrition
-
7/30/2019 Nutrition & Liver Disease
26/27
Medical nutrition therapy for liver
transplant
Pretransplantmalnutrition is common
Recommend small, frequent, nutritionally
complete meals, with enteral feedings as
necessary
Food-drug interactions are common
Posttransplantprovide nutritional
intervention as necessary for obesity,
hyperlipidemia, hypertension, diabetes, etc
-
7/30/2019 Nutrition & Liver Disease
27/27
References and recommended
resources
Hasse JM, Matarese LE. Medical nutrition
therapy for liver, biliary system, and exocrine
pancreas disorders. In: Mahan LK, Escott-
Stump S. Krauses Food, Nutrition, and Diet
Therapy. 11th ed. Philadelphia, PA: WB
Saunders; 2004:740-756.